Last 12 months
Inside the activity.
0 purchase rows · 7 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 4 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 09, 2023 Filed Jan 10, 2023 21:51 UTC |
Ho CaroleChief Medical Officer
|
SaleCommon Stock | 1,459 | $28.48 | $41,552.32 |
DisclosureSEC source: 0001714899-23-000017 · wf-form4_167338746261232.xml · nonDerivative · entry 1 Ho Carole · CIK 0001724605 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 177,454 F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan. F2 · ownership.nature: The shares are held of record by the Rohatgi-Ho Family 2009 Revocable Trust, for which Reporting Person serves as trustee. Read SEC document |
| January 06, 2023 Filed Jan 10, 2023 02:43 UTC |
Ho CaroleChief Medical Officer
|
SaleCommon Stock | 1,451 | $28.67 | $41,600.17 |
DisclosureSEC source: 0001714899-23-000016 · wf-form4_167331860319501.xml · nonDerivative · entry 2 Ho Carole · CIK 0001724605 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 178,913 F5 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan. F4 · ownership.nature: The shares are held of record by the Rohatgi-Ho Family 2009 Revocable Trust, for which Reporting Person serves as trustee. Read SEC document |
| January 05, 2023 Filed Jan 10, 2023 02:41 UTC |
Watts Ryan J.Director · President and CEO
|
SaleCommon Stock | 4,800 | $28.44 | $136,512.00 |
DisclosureSEC source: 0001714899-23-000013 · wf-form4_167331845186326.xml · nonDerivative · entry 1 Watts Ryan J. · CIK 0001724310 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 2,223,664 F1 · kind: Shares sold to satisfy the tax obligations by the reporting person in connection with the settlement of previously vested restricted stock units. F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $28.17 to $28.70 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. F3 · balance_after: Reflects the issuance of shares to the Watts Family 2015 Trust in connection with the vesting of 15,000 restricted stock units held by the Reporting Person. F4 · ownership.nature: The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee. Read SEC document |
| January 05, 2023 Filed Jan 10, 2023 02:41 UTC |
Schuth Alexander O.COFO and Secretary
|
SaleCommon Stock | 2,636 | $28.44 | $74,967.84 |
DisclosureSEC source: 0001714899-23-000014 · wf-form4_167331850392461.xml · nonDerivative · entry 1 Schuth Alexander O. · CIK 0001724311 · COFO and Secretary 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 497,173 F1 · kind: Shares sold to satisfy the tax obligations by the Reporting Person in connection with the settlement of previously vested restricted stock units. F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $28.17 to $28.68 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. F3 · balance_after: Reflects the issuance of shares to The Schuth Family Trust U/A DTD 06/05/2017 in connection with the vesting of 7,500 RSUs held by the Reporting Person. F4 · ownership.nature: The shares are held of record by The Schuth Family Trust U/A DTD 06/05/2017, for which the Reporting Person serves as trustee. Read SEC document |
| January 05, 2023 Filed Jan 10, 2023 02:42 UTC |
Krognes Steve E.Director
|
SaleCommon Stock | 2,970 | $28.44 | $84,466.80 |
DisclosureSEC source: 0001714899-23-000015 · wf-form4_167331855351574.xml · nonDerivative · entry 1 Krognes Steve E. · CIK 0001666236 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 146,498 F1 · kind: Shares sold to satisfy the tax obligations by the reporting person in connection with the settlement of previously vested restricted stock units. F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $28.17 to $28.70 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. F3 · balance_after: Includes 43,822 restricted stock units. Read SEC document |
| January 05, 2023 Filed Jan 10, 2023 02:43 UTC |
Ho CaroleChief Medical Officer
|
SaleCommon Stock | 2,636 | $28.44 | $74,967.84 |
DisclosureSEC source: 0001714899-23-000016 · wf-form4_167331860319501.xml · nonDerivative · entry 1 Ho Carole · CIK 0001724605 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 180,364 F1 · kind: Shares sold to satisfy the tax obligations by the reporting person in connection with the settlement of previously vested restricted stock units. F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $28.17 to $28.68 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. F3 · balance_after: Reflects the issuance of shares to the Rohatgi-Ho Family 2009 Revocable Trust in connection with the vesting of 7,500 RSUs held by the Reporting Person. F4 · ownership.nature: The shares are held of record by the Rohatgi-Ho Family 2009 Revocable Trust, for which Reporting Person serves as trustee. Read SEC document |
| January 04, 2023 Filed Jan 6, 2023 02:08 UTC |
Ho CaroleChief Medical Officer
|
SaleCommon Stock | 2,913 | $28.69 | $83,573.97 |
DisclosureSEC source: 0001209191-23-002184 · doc4.xml · nonDerivative · entry 2 Ho Carole · CIK 0001724605 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 175,500 F4 · kind: Shares sold to satisfy the tax obligations by the Reporting Person in connection with the settlement of previously vested RSUs. F5 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $28.48 to $28.97 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. F3 · balance_after: Reflects the issuance of shares to the Rohatgi-Ho Family 2009 Revocable Trust in connection with the vesting of 7,750 RSUs held by the Reporting Person. F6 · ownership.nature: The shares are held of record by the Rohatgi-Ho Family 2009 Revocable Trust, for which Reporting Person serves as trustee. Read SEC document |
| January 04, 2023 Filed Jan 6, 2023 02:07 UTC |
Watts Ryan J.Director · President and CEO
|
SaleCommon Stock | 5,029 | $28.73 | $144,483.17 |
DisclosureSEC source: 0001209191-23-002179 · doc4.xml · nonDerivative · entry 2 Watts Ryan J. · CIK 0001724310 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 2,213,464 F4 · kind: Shares sold to satisfy the tax obligations by the Reporting Person in connection with the settlement of previously vested RSUs. F5 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $28.58 to $29.00 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. F2 · balance_after: Reflects the issuance of shares to the Watts Family 2015 Trust in connection with the vesting of 15,500 RSUs held by the Reporting Person. F6 · ownership.nature: The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee. Read SEC document |
| January 04, 2023 Filed Jan 6, 2023 02:07 UTC |
Schuth Alexander O.COFO and Secretary
|
SaleCommon Stock | 2,912 | $28.70 | $83,574.40 |
DisclosureSEC source: 0001209191-23-002181 · doc4.xml · nonDerivative · entry 2 Schuth Alexander O. · CIK 0001724311 · COFO and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 149,828 F3 · kind: Shares sold to satisfy the tax obligations by the Reporting Person in connection with the settlement of previously vested RSUs. F4 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $28.48 to $28.96 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. F2 · balance_after: Includes 138,192 RSUs. F5 · balance_after: Reflects the issuance of shares to The Schuth Family Trust U/A DTD 06/05/2017 in connection with the vesting of 7,750 RSUs held by the Reporting Person. Read SEC document |
| January 04, 2023 Filed Jan 9, 2023 21:05 UTC Amendment |
Schuth Alexander O.COFO and Secretary
|
SaleCommon Stock | 2,912 | $28.70 | $83,574.40 |
DisclosureSEC source: 0001209191-23-002545 · doc4a.xml · nonDerivative · entry 1 Schuth Alexander O. · CIK 0001724311 · COFO and Secretary 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 492,309 F1 · kind: Shares sold to satisfy the tax obligations by the Reporting Person in connection with the settlement of previously vested RSUs. F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $28.48 to $28.96 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. F3 · balance_after: Reflects the issuance of shares to The Schuth Family Trust U/A DTD 06/05/2017 in connection with the vesting of 7,750 RSUs held by the Reporting Person. F4 · ownership.nature: The shares are held of record by The Schuth Family Trust U/A DTD 06/05/2017, for which the Reporting Person serves as trustee. Read SEC document |
| January 03, 2023 Filed Jan 6, 2023 02:08 UTC |
Ho CaroleChief Medical Officer
|
GrantStock Option (right to buy) · Derivative | 123,360 | $0.00 Strike: $27.63 | $0.00 |
DisclosureSEC source: 0001209191-23-002184 · doc4.xml · derivative · entry 4 Ho Carole · CIK 0001724605 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,360 Underlying: Common Stock · 123,360 shares Expires 2033-01-02 F8 · derivative.exercise_date: 25% of the shares subject to the option shall vest on January 3, 2024, and 1/48 of the shares subject to the option shall vest each month thereafter, subject to the Reporting Person remaining a service provider of the Issuer through each such date. Read SEC document |
| January 03, 2023 Filed Jan 6, 2023 02:08 UTC |
Ho CaroleChief Medical Officer
|
GrantCommon Stock | 41,120 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-002184 · doc4.xml · nonDerivative · entry 1 Ho Carole · CIK 0001724605 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,967 F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU") and a contingent right to receive one share of common stock of the Issuer. 25% of the RSUs shall vest on January 3, 2024 (the "Vesting Commencement Date") and an additional 25% of the RSUs shall vest on each annual anniversary of the Vesting Commencement Date thereafter, subject to the Reporting Person remaining a service provider of the Issuer through each such date. F2 · balance_after: Includes 138,557 RSUs. F3 · balance_after: Reflects the issuance of shares to the Rohatgi-Ho Family 2009 Revocable Trust in connection with the vesting of 7,750 RSUs held by the Reporting Person. Read SEC document |
| January 03, 2023 Filed Jan 6, 2023 02:07 UTC |
Watts Ryan J.Director · President and CEO
|
GrantStock Option (right to buy) · Derivative | 246,720 | $0.00 Strike: $27.63 | $0.00 |
DisclosureSEC source: 0001209191-23-002179 · doc4.xml · derivative · entry 3 Watts Ryan J. · CIK 0001724310 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 246,720 Underlying: Common Stock · 246,720 shares Expires 2033-01-02 F7 · derivative.exercise_date: 25% of the shares subject to the option shall vest on January 3, 2024, and 1/48 of the shares subject to the option shall vest each month thereafter, subject to the Reporting Person remaining a service provider of the Issuer through each such date. Read SEC document |
| January 03, 2023 Filed Jan 6, 2023 02:07 UTC |
Watts Ryan J.Director · President and CEO
|
GrantCommon Stock | 82,240 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-002179 · doc4.xml · nonDerivative · entry 1 Watts Ryan J. · CIK 0001724310 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 231,934 F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU") and a contingent right to receive one share of common stock of the Issuer. 25% of the RSUs shall vest on January 3, 2024 (the "Vesting Commencement Date") and an additional 25% of the RSUs shall vest on each annual anniversary of the Vesting Commencement Date thereafter, subject to the Reporting Person remaining a service provider of the Issuer through each such date. F2 · balance_after: Reflects the issuance of shares to the Watts Family 2015 Trust in connection with the vesting of 15,500 RSUs held by the Reporting Person. F3 · balance_after: Includes 231,934 RSUs. Read SEC document |
| January 03, 2023 Filed Jan 6, 2023 02:07 UTC |
Schuth Alexander O.COFO and Secretary
|
GrantStock Option (right to buy) · Derivative | 123,360 | $0.00 Strike: $27.63 | $0.00 |
DisclosureSEC source: 0001209191-23-002181 · doc4.xml · derivative · entry 4 Schuth Alexander O. · CIK 0001724311 · COFO and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,360 Underlying: Common Stock · 123,360 shares Expires 2033-01-02 F7 · derivative.exercise_date: 25% of the shares subject to the option shall vest on January 3, 2024, and 1/48 of the shares subject to the option shall vest each month thereafter, subject to the Reporting Person remaining a service provider of the Issuer through each such date. Read SEC document |
| January 03, 2023 Filed Jan 6, 2023 02:07 UTC |
Schuth Alexander O.COFO and Secretary
|
GrantCommon Stock | 41,120 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-002181 · doc4.xml · nonDerivative · entry 1 Schuth Alexander O. · CIK 0001724311 · COFO and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 157,578 F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU") and a contingent right to receive one share of common stock of the Issuer. 25% of the RSUs shall vest on January 3, 2024 (the "Vesting Commencement Date") and an additional 25% of the RSUs shall vest on each annual anniversary of the Vesting Commencement Date thereafter, subject to the Reporting Person remaining a service provider of the Issuer through each such date. F2 · balance_after: Includes 138,192 RSUs. Read SEC document |
| November 23, 2022 Filed Nov 29, 2022 00:30 UTC |
Tessier-Lavigne MarcDirector
|
SaleCommon Stock | 20,000 | $30.48 | $609,600.00 |
DisclosureSEC source: 0001714899-22-000148 · wf-form4_166968178535428.xml · nonDerivative · entry 1 Tessier-Lavigne Marc · CIK 0001437435 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,870,356 F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $30.15 to $31.09 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. F3 · balance_after: Includes 5,986 unvested restricted stock units. Read SEC document |
| November 02, 2022 Filed Nov 3, 2022 21:37 UTC |
Tessier-Lavigne MarcDirector
|
SaleCommon Stock | 11,252 | $30.33 | $341,273.16 |
DisclosureSEC source: 0001714899-22-000146 · wf-form4_166751143725460.xml · nonDerivative · entry 2 Tessier-Lavigne Marc · CIK 0001437435 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,890,356 F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $30.00 to $30.90 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. F3 · balance_after: Includes 5,986 unvested restricted stock units. Read SEC document |
| November 01, 2022 Filed Nov 3, 2022 21:37 UTC |
Tessier-Lavigne MarcDirector
|
SaleCommon Stock | 8,748 | $30.20 | $264,189.60 |
DisclosureSEC source: 0001714899-22-000146 · wf-form4_166751143725460.xml · nonDerivative · entry 1 Tessier-Lavigne Marc · CIK 0001437435 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,901,608 F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $30.00 to $30.48 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. F3 · balance_after: Includes 5,986 unvested restricted stock units. Read SEC document |
| October 07, 2022 Filed Oct 12, 2022 20:05 UTC |
Schuth Alexander O.COFO and Secretary
|
Exercise / conversionStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $0.68 | $0.00 |
DisclosureSEC source: 0001714899-22-000135 · wf-form4_166560511822999.xml · derivative · entry 3 Schuth Alexander O. · CIK 0001724311 · COFO and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 220,078 Underlying: Common Stock · 20,000 shares Expires 2025-08-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The vesting of the shares subject to the option is contingent upon the achievement of certain performance metrics. 50% of the shares subject to the option vested on the date the closing price of Issuer's Common Stock equaled or exceeded $40.00 per share on NASDAQ for 90 consecutive trading days, beginning no earlier than June 10, 2018; and 50% of the shares subject to the option vest on the date the closing price of Issuer's Common Stock equals or exceeds $80.00 per share on NASDAQ for 90 consecutive trading days, beginning no earlier than June 10, 2018. Read SEC document |
| October 07, 2022 Filed Oct 12, 2022 20:05 UTC |
Schuth Alexander O.COFO and Secretary
|
Exercise / conversionCommon Stock | 20,000 | $0.68 | $13,600.00 |
DisclosureSEC source: 0001714899-22-000135 · wf-form4_166560511822999.xml · nonDerivative · entry 1 Schuth Alexander O. · CIK 0001724311 · COFO and Secretary 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 487,471 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Exercised shares were issued to the Schuth Family Trust. F2 · ownership.nature: The shares are held of record by The Schuth Family Trust U/A DTD 06/05/2017, for which the Reporting Person serves as trustee. Read SEC document |
| September 28, 2022 Filed Sep 30, 2022 20:50 UTC |
Tessier-Lavigne MarcDirector
|
SaleCommon Stock | 4,423 | $31.08 | $137,466.84 |
DisclosureSEC source: 0001714899-22-000133 · wf-form4_166457103687475.xml · nonDerivative · entry 2 Tessier-Lavigne Marc · CIK 0001437435 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,910,356 F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $31.00 to $31.31 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. F3 · balance_after: Includes 5,986 unvested restricted stock units. Read SEC document |
| September 28, 2022 Filed Sep 30, 2022 20:50 UTC |
Tessier-Lavigne MarcDirector
|
SaleCommon Stock | 15,577 | $30.74 | $478,836.98 |
DisclosureSEC source: 0001714899-22-000133 · wf-form4_166457103687475.xml · nonDerivative · entry 1 Tessier-Lavigne Marc · CIK 0001437435 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,914,779 F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $30.00 to $30.99 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. F3 · balance_after: Includes 5,986 unvested restricted stock units. Read SEC document |
| August 23, 2022 Filed Aug 25, 2022 22:10 UTC |
Ho CaroleChief Medical Officer
|
SaleCommon Stock | 2,424 | $31.98 | $77,519.52 |
DisclosureSEC source: 0001714899-22-000130 · wf-form4_166146541259069.xml · nonDerivative · entry 1 Ho Carole · CIK 0001724605 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 170,663 F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan. F2 · ownership.nature: The shares are held of record by the Rohatgi-Ho Family 2009 Revocable Trust, for which Reporting Person serves as trustee. Read SEC document |
| August 23, 2022 Filed Aug 25, 2022 22:11 UTC |
Tessier-Lavigne MarcDirector
|
SaleCommon Stock | 100 | $32.43 | $3,243.00 |
DisclosureSEC source: 0001714899-22-000131 · wf-form4_166146545134466.xml · nonDerivative · entry 2 Tessier-Lavigne Marc · CIK 0001437435 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,930,356 F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan. F3 · balance_after: Includes 5,986 unvested restricted stock units. Read SEC document |
| August 23, 2022 Filed Aug 25, 2022 22:11 UTC |
Tessier-Lavigne MarcDirector
|
SaleCommon Stock | 19,900 | $31.61 | $629,039.00 |
DisclosureSEC source: 0001714899-22-000131 · wf-form4_166146545134466.xml · nonDerivative · entry 1 Tessier-Lavigne Marc · CIK 0001437435 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,930,456 F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $31.33 to $32.31 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. F3 · balance_after: Includes 5,986 unvested restricted stock units. Read SEC document |
| August 19, 2022 Filed Aug 23, 2022 20:48 UTC |
Watts Ryan J.Director · President and CEO
|
SaleCommon Stock | 2,404 | $33.22 | $79,860.88 |
DisclosureSEC source: 0001714899-22-000129 · wf-form4_166128769265555.xml · nonDerivative · entry 1 Watts Ryan J. · CIK 0001724310 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 2,202,993 F1 · kind: Shares sold to satisfy the tax obligations by the reporting person in connection with the settlement of previously vested restricted stock units. F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $33.11 to $33.37 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. F3 · balance_after: Reflects the issuance of shares to the Watts Family 2015 Trust in connection with the vesting of 5,000 restricted stock units held by the Reporting Person. F4 · ownership.nature: The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee. Read SEC document |
| August 19, 2022 Filed Aug 23, 2022 20:46 UTC |
Schuth Alexander O.COFO and Secretary
|
SaleCommon Stock | 2,576 | $33.22 | $85,574.72 |
DisclosureSEC source: 0001714899-22-000127 · wf-form4_166128759380161.xml · nonDerivative · entry 1 Schuth Alexander O. · CIK 0001724311 · COFO and Secretary 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 467,471 F1 · kind: Shares sold to satisfy the tax obligations by the reporting person in connection with the settlement of previously vested restricted stock units. F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $33.11 to $33.38 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. F3 · balance_after: Reflects the issuance of shares to the Schuth Family 2017 Trust in connection with the vesting of 5,000 restricted stock units held by the Reporting Person. F4 · ownership.nature: The shares are held of record by The Schuth Family Trust U/A DTD 06/05/2017, for which the Reporting Person serves as trustee. Read SEC document |
| August 19, 2022 Filed Aug 23, 2022 20:47 UTC |
Krognes Steve E.Director
|
SaleCommon Stock | 2,253 | $33.22 | $74,844.66 |
DisclosureSEC source: 0001714899-22-000128 · wf-form4_166128765076444.xml · nonDerivative · entry 1 Krognes Steve E. · CIK 0001666236 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 149,468 F1 · kind: Shares sold to satisfy the tax obligations by the reporting person in connection with the settlement of previously vested restricted stock units. F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $33.11 to $33.37 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. F3 · balance_after: Includes 51,322 restricted stock units. Read SEC document |
| August 19, 2022 Filed Aug 23, 2022 20:45 UTC |
Ho CaroleChief Medical Officer
|
SaleCommon Stock | 2,576 | $33.22 | $85,574.72 |
DisclosureSEC source: 0001714899-22-000126 · wf-form4_166128752453768.xml · nonDerivative · entry 1 Ho Carole · CIK 0001724605 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 173,087 F1 · kind: Shares sold to satisfy the tax obligations by the reporting person in connection with the settlement of previously vested restricted stock units. F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $33.11 to $33.39 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. F3 · balance_after: Reflects the issuance of shares to the Rohatgi-Ho Family 2009 Revocable Trust in connection with the vesting of 5,000 restricted stock units held by the Reporting Person. F4 · ownership.nature: The shares are held of record by the Rohatgi-Ho Family 2009 Revocable Trust, for which Reporting Person serves as trustee. Read SEC document |
| August 09, 2022 Filed Aug 11, 2022 23:21 UTC |
Schuth Alexander O.COFO and Secretary
|
GrantCommon Stock | 22,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001714899-22-000124 · wf-form4_166026004225336.xml · nonDerivative · entry 1 Schuth Alexander O. · CIK 0001724311 · COFO and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,458 F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU") and a contingent right to receive one share of common stock of the Issuer. 25% of the RSUs shall vest on August 9, 2023 (the"Vesting Commencement Date") and an additional 25% of the RSUs shall vest on each annual anniversary of the Vesting Commencement Date thereafter, subject to the Reporting Person remaining a serviceprovider of the Issuer through each such date. F2 · balance_after: Includes 109,822 restricted stock units. F3 · balance_after: Includes 540 shares acquired under the ESPP Purchase on May 31, 2022. Read SEC document |
| August 09, 2022 Filed Aug 11, 2022 23:22 UTC |
Ho CaroleChief Medical Officer
|
GrantCommon Stock | 22,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001714899-22-000125 · wf-form4_166026015800698.xml · nonDerivative · entry 1 Ho Carole · CIK 0001724605 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,597 F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU") and a contingent right to receive one share of common stock of the Issuer. 25% of the RSUs shall vest on August 9, 2023 (the "Vesting Commencement Date") and an additional 25% of the RSUs shall vest on each annual anniversary of the Vesting Commencement Date thereafter, subject to the Reporting Person remaining a service provider ofthe Issuer through each such date. F2 · balance_after: Includes 110,187 restricted stock units. Read SEC document |
| July 25, 2022 Filed Jul 27, 2022 22:49 UTC |
Tessier-Lavigne MarcDirector
|
SaleCommon Stock | 200 | $36.15 | $7,230.00 |
DisclosureSEC source: 0001714899-22-000109 · wf-form4_165896213456047.xml · nonDerivative · entry 2 Tessier-Lavigne Marc · CIK 0001437435 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,950,356 F3 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $36.03 to $36.27 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. F2 · balance_after: Includes 5,986 unvested restricted stock units. Read SEC document |
| July 25, 2022 Filed Jul 27, 2022 22:49 UTC |
Tessier-Lavigne MarcDirector
|
SaleCommon Stock | 19,800 | $35.60 | $704,880.00 |
DisclosureSEC source: 0001714899-22-000109 · wf-form4_165896213456047.xml · nonDerivative · entry 1 Tessier-Lavigne Marc · CIK 0001437435 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,950,556 F1 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $35.02 to $36.01 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. F2 · balance_after: Includes 5,986 unvested restricted stock units. Read SEC document |
| July 19, 2022 Filed Jul 21, 2022 23:36 UTC |
Krognes Steve E.Director
|
Exercise / conversionStock Option (right to buy) · Derivative | 62,500 | $0.00 Strike: $0.68 | $0.00 |
DisclosureSEC source: 0001714899-22-000107 · wf-form4_165844658516817.xml · derivative · entry 3 Krognes Steve E. · CIK 0001666236 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 62,500 shares Expires 2022-08-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 25% of the shares subject to the option vested on March 8, 2018 and an additional 1/48 of the shares vested monthly thereafter. Read SEC document |
| July 19, 2022 Filed Jul 21, 2022 23:36 UTC |
Krognes Steve E.Director
|
Exercise / conversionCommon Stock | 62,500 | $0.68 | $42,500.00 |
DisclosureSEC source: 0001714899-22-000107 · wf-form4_165844658516817.xml · nonDerivative · entry 1 Krognes Steve E. · CIK 0001666236 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 151,721 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 56,322 restricted stock units. Read SEC document |
| June 24, 2022 Filed Jun 28, 2022 00:54 UTC |
Tessier-Lavigne MarcDirector
|
Disposition to issuerCommon Stock | 6,766 | $31.08 | $210,260.89 |
DisclosureSEC source: 0001628280-22-018113 · wf-form4_165637764875845.xml · nonDerivative · entry 3 Tessier-Lavigne Marc · CIK 0001437435 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,970,356 F4 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $31.00 to $31.19 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. F2 · balance_after: Includes 5,986 unvested restricted stock units. Read SEC document |
| June 24, 2022 Filed Jun 28, 2022 00:54 UTC |
Tessier-Lavigne MarcDirector
|
Disposition to issuerCommon Stock | 39,984 | $30.53 | $1,220,707.52 |
DisclosureSEC source: 0001628280-22-018113 · wf-form4_165637764875845.xml · nonDerivative · entry 2 Tessier-Lavigne Marc · CIK 0001437435 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,977,122 F3 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $30.00 to $30.99 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. F2 · balance_after: Includes 5,986 unvested restricted stock units. Read SEC document |
| June 23, 2022 Filed Jun 28, 2022 00:54 UTC |
Tessier-Lavigne MarcDirector
|
Disposition to issuerCommon Stock | 13,250 | $31.10 | $412,076.33 |
DisclosureSEC source: 0001628280-22-018113 · wf-form4_165637764875845.xml · nonDerivative · entry 1 Tessier-Lavigne Marc · CIK 0001437435 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,017,106 F1 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $30.00 to $30.19 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. F2 · balance_after: Includes 5,986 unvested restricted stock units. Read SEC document |
| June 02, 2022 Filed Jun 7, 2022 00:09 UTC |
Schenkein David PDirector
|
GrantStock Option (right to buy) · Derivative | 17,959 | $0.00 Strike: $24.27 | $0.00 |
DisclosureSEC source: 0001714899-22-000098 · wf-form4_165456058126311.xml · derivative · entry 4 Schenkein David P · CIK 0001578200 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,959 Underlying: Common Stock · 17,959 shares Expires 2032-06-02 F5 · derivative.exercise_date: 100% of the shares subject to the option shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date. Read SEC document |
| June 02, 2022 Filed Jun 7, 2022 00:09 UTC |
Schenkein David PDirector
|
GrantCommon Stock | 5,986 | $0.00 | $0.00 |
DisclosureSEC source: 0001714899-22-000098 · wf-form4_165456058126311.xml · nonDerivative · entry 1 Schenkein David P · CIK 0001578200 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,313 F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU") and a contingent right to receive one share of common stock of the Issuer. 100% of the RSUs shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date. F2 · balance_after: Includes 5,986 unvested restricted stock units. Read SEC document |
| June 02, 2022 Filed Jun 7, 2022 00:09 UTC |
Klein Peter SDirector
|
GrantStock Option (right to buy) · Derivative | 17,959 | $0.00 Strike: $24.27 | $0.00 |
DisclosureSEC source: 0001714899-22-000097 · wf-form4_165456056392230.xml · derivative · entry 2 Klein Peter S · CIK 0001478007 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,959 Underlying: Common Stock · 17,959 shares Expires 2032-06-02 F3 · derivative.exercise_date: 100% of the shares subject to the option shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date. Read SEC document |
| June 02, 2022 Filed Jun 7, 2022 00:09 UTC |
Klein Peter SDirector
|
GrantCommon Stock | 5,986 | $0.00 | $0.00 |
DisclosureSEC source: 0001714899-22-000097 · wf-form4_165456056392230.xml · nonDerivative · entry 1 Klein Peter S · CIK 0001478007 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,313 F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU") and a contingent right to receive one share of common stock of the Issuer. 100% of the RSUs shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date. F2 · balance_after: Includes 5,986 unvested restricted stock units. Read SEC document |
| June 02, 2022 Filed Jun 7, 2022 00:09 UTC |
Tessier-Lavigne MarcDirector
|
GrantStock Option (right to buy) · Derivative | 17,959 | $0.00 Strike: $24.27 | $0.00 |
DisclosureSEC source: 0001714899-22-000096 · wf-form4_165456054624289.xml · derivative · entry 5 Tessier-Lavigne Marc · CIK 0001437435 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,959 Underlying: Common Stock · 17,959 shares Expires 2032-06-02 F3 · derivative.exercise_date: 100% of the shares subject to the option shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date. Read SEC document |
| June 02, 2022 Filed Jun 7, 2022 00:09 UTC |
Tessier-Lavigne MarcDirector
|
GrantCommon Stock | 5,986 | $0.00 | $0.00 |
DisclosureSEC source: 0001714899-22-000096 · wf-form4_165456054624289.xml · nonDerivative · entry 1 Tessier-Lavigne Marc · CIK 0001437435 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,030,356 F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU") and a contingent right to receive one share of common stock of the Issuer. 100% of the RSUs shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date. F2 · balance_after: Includes 5,986 unvested restricted stock units. Read SEC document |
| June 02, 2022 Filed Jun 7, 2022 00:09 UTC |
Cole Douglas G.Director
|
GrantStock Option (right to buy) · Derivative | 17,959 | $0.00 Strike: $24.27 | $0.00 |
DisclosureSEC source: 0001714899-22-000095 · wf-form4_165456052861515.xml · derivative · entry 2 Cole Douglas G. · CIK 0001486373 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,959 Underlying: Common Stock · 17,959 shares Expires 2032-06-02 F4 · derivative.exercise_date: 100% of the shares subject to the option shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date. Read SEC document |
| June 02, 2022 Filed Jun 7, 2022 00:09 UTC |
Cole Douglas G.Director
|
GrantCommon Stock | 5,986 | $0.00 | $0.00 |
DisclosureSEC source: 0001714899-22-000095 · wf-form4_165456052861515.xml · nonDerivative · entry 1 Cole Douglas G. · CIK 0001486373 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,348 F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU") and a contingent right to receive one share of common stock of the Issuer. 100% of the RSUs shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date. F2 · balance_after: Includes 11,035 shares received in prior distributions-in-kind made in accordance with the exemptions afforded by Rule 16a-13 and Rule 16a-9 of the Securities Exchange Act of 1934, as amended. F3 · balance_after: Includes 5,986 unvested restricted stock units. Read SEC document |
| June 02, 2022 Filed Jun 7, 2022 00:08 UTC |
SATO VICKI LDirector
|
GrantStock Option (right to buy) · Derivative | 17,959 | $0.00 Strike: $24.27 | $0.00 |
DisclosureSEC source: 0001714899-22-000094 · wf-form4_165456050784142.xml · derivative · entry 2 SATO VICKI L · CIK 0001197020 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,959 Underlying: Common Stock · 17,959 shares Expires 2032-06-02 F3 · derivative.exercise_date: 100% of the shares subject to the option shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date. Read SEC document |
| June 02, 2022 Filed Jun 7, 2022 00:08 UTC |
SATO VICKI LDirector
|
GrantCommon Stock | 5,986 | $0.00 | $0.00 |
DisclosureSEC source: 0001714899-22-000094 · wf-form4_165456050784142.xml · nonDerivative · entry 1 SATO VICKI L · CIK 0001197020 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,149 F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU") and a contingent right to receive one share of common stock of the Issuer. 100% of the RSUs shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date. F2 · balance_after: Includes 5,986 unvested restricted stock units. Read SEC document |
| June 02, 2022 Filed Jun 7, 2022 00:08 UTC |
Cook Jennifer E.Director
|
GrantStock Option (right to buy) · Derivative | 17,959 | $0.00 Strike: $24.27 | $0.00 |
DisclosureSEC source: 0001714899-22-000093 · wf-form4_165456048293686.xml · derivative · entry 2 Cook Jennifer E. · CIK 0001754371 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,959 Underlying: Common Stock · 17,959 shares Expires 2032-06-02 F3 · derivative.exercise_date: 100% of the shares subject to the option shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.